Pharmacological plasticity—How do you hit a moving target?

Abstract Paul Ehrlich's concept of the magic bullet, by which a single drug induces pharmacological effects by interacting with a single receptor has been a strong driving force in pharmacology for a century. It is continually thwarted, though, by the fact that the treated organism is highly dy...

Full description

Bibliographic Details
Main Authors: Michael J. Parnham, Gerd Geisslinger
Format: Article
Language:English
Published: Wiley 2019-12-01
Series:Pharmacology Research & Perspectives
Subjects:
Online Access:https://doi.org/10.1002/prp2.532
id doaj-b48b04601b864c9d845de468b0d4bd6d
record_format Article
spelling doaj-b48b04601b864c9d845de468b0d4bd6d2021-05-02T08:10:07ZengWileyPharmacology Research & Perspectives2052-17072019-12-0176n/an/a10.1002/prp2.532Pharmacological plasticity—How do you hit a moving target?Michael J. Parnham0Gerd Geisslinger1Fraunhofer Institute for Molecular Biology & Applied Ecology IME Branch for Translational Medicine and Pharmacology TMP Frankfurt am Main GermanyFraunhofer Institute for Molecular Biology & Applied Ecology IME Branch for Translational Medicine and Pharmacology TMP Frankfurt am Main GermanyAbstract Paul Ehrlich's concept of the magic bullet, by which a single drug induces pharmacological effects by interacting with a single receptor has been a strong driving force in pharmacology for a century. It is continually thwarted, though, by the fact that the treated organism is highly dynamic and the target molecule(s) is (are) never static. In this article, we address some of the factors that modify and cause the mobility and plasticity of drug targets and their interactions with ligands and discuss how these can lead to unexpected (lack of) effects of drugs. These factors include genetic, epigenetic, and phenotypic variability, cellular plasticity, chronobiological rhythms, time, age and disease resolution, sex, drug metabolism, and distribution. We emphasize four existing approaches that can be taken, either singly or in combination, to try to minimize effects of pharmacological plasticity. These are firstly, to enhance specificity using target conditions close to those in diseases, secondly, by simultaneously or thirdly, sequentially aiming at multiple targets, and fourthly, in synchronization with concurrent dietary, psychological, training, and biorhythm‐synchronizing procedures to optimize drug therapy.https://doi.org/10.1002/prp2.532chronobiologydrug metabolism and distributiondrug targetsDrug therapytarget variability
collection DOAJ
language English
format Article
sources DOAJ
author Michael J. Parnham
Gerd Geisslinger
spellingShingle Michael J. Parnham
Gerd Geisslinger
Pharmacological plasticity—How do you hit a moving target?
Pharmacology Research & Perspectives
chronobiology
drug metabolism and distribution
drug targets
Drug therapy
target variability
author_facet Michael J. Parnham
Gerd Geisslinger
author_sort Michael J. Parnham
title Pharmacological plasticity—How do you hit a moving target?
title_short Pharmacological plasticity—How do you hit a moving target?
title_full Pharmacological plasticity—How do you hit a moving target?
title_fullStr Pharmacological plasticity—How do you hit a moving target?
title_full_unstemmed Pharmacological plasticity—How do you hit a moving target?
title_sort pharmacological plasticity—how do you hit a moving target?
publisher Wiley
series Pharmacology Research & Perspectives
issn 2052-1707
publishDate 2019-12-01
description Abstract Paul Ehrlich's concept of the magic bullet, by which a single drug induces pharmacological effects by interacting with a single receptor has been a strong driving force in pharmacology for a century. It is continually thwarted, though, by the fact that the treated organism is highly dynamic and the target molecule(s) is (are) never static. In this article, we address some of the factors that modify and cause the mobility and plasticity of drug targets and their interactions with ligands and discuss how these can lead to unexpected (lack of) effects of drugs. These factors include genetic, epigenetic, and phenotypic variability, cellular plasticity, chronobiological rhythms, time, age and disease resolution, sex, drug metabolism, and distribution. We emphasize four existing approaches that can be taken, either singly or in combination, to try to minimize effects of pharmacological plasticity. These are firstly, to enhance specificity using target conditions close to those in diseases, secondly, by simultaneously or thirdly, sequentially aiming at multiple targets, and fourthly, in synchronization with concurrent dietary, psychological, training, and biorhythm‐synchronizing procedures to optimize drug therapy.
topic chronobiology
drug metabolism and distribution
drug targets
Drug therapy
target variability
url https://doi.org/10.1002/prp2.532
work_keys_str_mv AT michaeljparnham pharmacologicalplasticityhowdoyouhitamovingtarget
AT gerdgeisslinger pharmacologicalplasticityhowdoyouhitamovingtarget
_version_ 1721493879918690304